Section 32 Fund 1, Lp - Net Worth and Insider Trading
Section 32 Fund 1, Lp Net Worth
The estimated net worth of Section 32 Fund 1, Lp is at least $94 Million dollars as of 2024-11-13. Section 32 Fund 1, Lp is the 10% Owner of Dave Inc and owns about 1,028,232 shares of Dave Inc (DAVE) stock worth over $94 Million. Details can be seen in Section 32 Fund 1, Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Section 32 Fund 1, Lp has not made any transactions after 2024-10-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Section 32 Fund 1, Lp
Section 32 Fund 1, Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Section 32 Fund 1, Lp owns 3 companies in total, including X4 Pharmaceuticals Inc (XFOR) , Dave Inc (DAVE) , and VPC Impact Acquisition Holdings III Inc (VPCC.U) .
Click here to see the complete history of Section 32 Fund 1, Lp’s form 4 insider trades.
Insider Ownership Summary of Section 32 Fund 1, Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XFOR | X4 Pharmaceuticals Inc | 2017-11-15 | 10 percent owner |
| DAVE | Dave Inc | 2024-10-09 | 10 percent owner |
| VPCC.U | VPC Impact Acquisition Holdings III Inc | 2022-08-08 | 10 percent owner |
Section 32 Fund 1, Lp Latest Holdings Summary
Section 32 Fund 1, Lp currently owns a total of 1 stock. Section 32 Fund 1, Lp owns 1,028,232 shares of Dave Inc (DAVE) as of October 9, 2024, with a value of $94 Million.
Section 32 Fund 1, Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Section 32 Fund 1, Lp has made a total of 10 transactions in Dave Inc (DAVE) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Dave Inc is the sale of 1,000,000 shares on October 9, 2024, which brought Section 32 Fund 1, Lp around $41 Million.
Insider Trading History of Section 32 Fund 1, Lp
- 1
Section 32 Fund 1, Lp Trading Performance
Section 32 Fund 1, Lp Ownership Network
Ownership Network List of Section 32 Fund 1, Lp
Ownership Network Relation of Section 32 Fund 1, Lp
Section 32 Fund 1, Lp Owned Company Details
What does X4 Pharmaceuticals Inc do?
Who are the key executives at X4 Pharmaceuticals Inc?
Section 32 Fund 1, Lp is the 10 percent owner of X4 Pharmaceuticals Inc. Other key executives at X4 Pharmaceuticals Inc include director & President and CEO Paula Ragan , Chief Scientific Officer Arthur Taveras , and Chief Operating Officer Mary Dibiase .
X4 Pharmaceuticals Inc (XFOR) Insider Trades Summary
Over the past 18 months, Section 32 Fund 1, Lp made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 601,883 shares made by Paula Ragan , a net sale of 161,480 shares made by Mary Dibiase , and a net sale of 552,345 shares made by Adam S. Mostafa .
In summary, during the past 3 months, insiders sold 660,362 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 660,362 shares. During the past 18 months, 1,626,785 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 1,601,785 shares.
X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.
X4 Pharmaceuticals Inc Insider Transactions
Section 32 Fund 1, Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Section 32 Fund 1, Lp. You might contact Section 32 Fund 1, Lp via mailing address: 169 University Ave., Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
